Abstract Background Monotonically expressed genes (MEGs) are genes whose expression values increase or decrease monotonically as a disease advances or time proceeds. Non-small cell lung cancer (NSCLC) is a multistage progression process resulting from genetic sequences mutations, the identification of MEGs for NSCLC is important. Results With the aid of a feature selection algorithm capable of identifying MEGs – the MFSelector method – two sets of potential MEGs were selected in this study: the MEGs across the different pathologic stages and the MEGs across the risk levels of death for the NSCLC patients at early stages. For the lung adenocarcinoma (AC) subtypes no statistically significant MEGs were identified across pathologic stages, how...
Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patient...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...
Background: Lung adenocarcinoma (LUAD) shows intratumoral heterogeneity, a highly complex phenomenon...
Given the fact that cancer is a multistage progression process resulting from genetic sequence mutat...
NSCLC (non-small cell lung cancer) comprises about 80% of all lung cancer cases worldwide. Surgery i...
Among non-small cell lung cancer (NSCLC), adenocarcinoma (AC), and squamous cell carcinoma (SCC) are...
Objective To construct a diagnostic signature to distinguish lung adenocarcinoma from lung squamous ...
BACKGROUND: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. Global expressi...
We performed a series of bioinformatics analysis on a set of important gene expression data with 76 ...
The progression of non-small cell lung cancer (NSCLC) is linked to epithelial-mesenchymal transition...
Background: Lung adenocarcinoma (LUAD) shows intratumoral heterogeneity, a highly complex phenomenon...
Abstract Background The purpose of this study was to achieve early and accurate diagnosis of lung ca...
Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patient...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...
Background: Lung adenocarcinoma (LUAD) shows intratumoral heterogeneity, a highly complex phenomenon...
Given the fact that cancer is a multistage progression process resulting from genetic sequence mutat...
NSCLC (non-small cell lung cancer) comprises about 80% of all lung cancer cases worldwide. Surgery i...
Among non-small cell lung cancer (NSCLC), adenocarcinoma (AC), and squamous cell carcinoma (SCC) are...
Objective To construct a diagnostic signature to distinguish lung adenocarcinoma from lung squamous ...
BACKGROUND: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. Global expressi...
We performed a series of bioinformatics analysis on a set of important gene expression data with 76 ...
The progression of non-small cell lung cancer (NSCLC) is linked to epithelial-mesenchymal transition...
Background: Lung adenocarcinoma (LUAD) shows intratumoral heterogeneity, a highly complex phenomenon...
Abstract Background The purpose of this study was to achieve early and accurate diagnosis of lung ca...
Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patient...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...
Background: Lung adenocarcinoma (LUAD) shows intratumoral heterogeneity, a highly complex phenomenon...